This research is being done to see if the drug Inqov is effective in reducing the chance of
myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) relapsing after
standard of care stem cell transplant.
- This research study involves the study drug Inqovi, which is a combination of the drugs
decitabine and cedazuridine.